WHO MiNDbank: More Inclusiveness Needed in Disability and Development

A database of resources covering mental health, substance abuse, disability, general health, human rights and development

Ley de Reforma y Adiciones a la Ley No. 177, Ley de Estupefacientes, Sicotrópicos y Sustancias Controladas - Ley No. 285 (Act on the Amendments and Additions to Act No. 177. Act on Narcotics, Psychotropic Substances and Other Controlled Substances - Act No. 285)

Republic of Nicaragua National Assembly of Nicaragua Country Resources Substance Abuse Legislation Nicaragua 16 April 1999 Legislation/regulation drugs legislation, rehabilitation, substance use

This translation feature uses a third-party service. Please be advised that the machine-translated content may not be accurate. Translation only applies to this page and is not available for downloaded files or external links.

Print

Description

La ley Número 285 es la ley que reforma y adiciona la ley número 177, ley de estupefacientes, sicotrópicos y sustancias controladas. Fue aprobada en 1999, y contiene 98 artículos.

Regula lo siguiente: la prevención, tratamiento, rehabilitación, control, supervisión, investigación, persecución de cualquier actividad relacionada con el cultivo, la producción, la fabricación, el uso, la posesión, el transporte, el tráfico y toda forma de comercialización de los medicamentos, psicotrópicos, precursores y otros productos químicos y sustancias inhalables susceptibles de producir dependencia física o psicológica.


The act number 285 is the act on the amendments and additions to Act No. 177, the act on narcotics, psychotropic substances and other controlled substances. It was passed in 1999 and it contains 98 articles.

This law regulates the following: prevention, treatment, rehabilitation, control, supervision, investigation, prosecution of any activity relating to the cultivation, production, manufacture, use, possession, transportation, traffic and all form of commercialization of drugs, psychotropics, precursors and other chemicals and inhalants likely to produce physical or psychological dependence.

Content

WHO collates and provides external links to resources focusing on mental health, disability, general health, human rights and development but does not specifically endorse particular laws, policies, plans or other documents from countries or organisations. WHO also does not warrant that the information in this record is correct or refers to the most up-to-date version. Please read the site disclaimer for further details. If this record contains an error or is outdated, please notify us.